AU2015201757A1 - Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction - Google Patents

Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction

Info

Publication number
AU2015201757A1
AU2015201757A1 AU2015201757A AU2015201757A AU2015201757A1 AU 2015201757 A1 AU2015201757 A1 AU 2015201757A1 AU 2015201757 A AU2015201757 A AU 2015201757A AU 2015201757 A AU2015201757 A AU 2015201757A AU 2015201757 A1 AU2015201757 A1 AU 2015201757A1
Authority
AU
Australia
Prior art keywords
sirpalpha
interaction
compositions
methods
hematologic cancers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015201757A
Inventor
Jayne Danska
John Dick
Liqing Jin
Sujeetha Rajakumar
Alexandre Theocharides
C. Y. Jean Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
University Health Network
Original Assignee
Hospital for Sick Children HSC
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC, University Health Network filed Critical Hospital for Sick Children HSC
Publication of AU2015201757A1 publication Critical patent/AU2015201757A1/en
Priority to AU2017200201A priority Critical patent/AU2017200201A1/en
Priority to AU2018256470A priority patent/AU2018256470A1/en
Priority to AU2020220183A priority patent/AU2020220183A1/en
Priority to AU2022256193A priority patent/AU2022256193A1/en
Abandoned legal-status Critical Current

Links

AU2015201757A 2009-05-15 2015-04-08 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction Abandoned AU2015201757A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2017200201A AU2017200201A1 (en) 2009-05-15 2017-01-12 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction
AU2018256470A AU2018256470A1 (en) 2009-05-15 2018-10-29 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction
AU2020220183A AU2020220183A1 (en) 2009-05-15 2020-08-21 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction
AU2022256193A AU2022256193A1 (en) 2009-05-15 2022-10-21 Compositions and methods for treating hematologic cancers targeting the SIRPa-CD47 interaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/178,553 2009-05-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010246872A Division AU2010246872B2 (en) 2009-05-15 2010-05-14 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017200201A Division AU2017200201A1 (en) 2009-05-15 2017-01-12 Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction

Publications (1)

Publication Number Publication Date
AU2015201757A1 true AU2015201757A1 (en) 2015-04-30

Family

ID=

Similar Documents

Publication Publication Date Title
PL2429574T3 (en) Compositions and methods for treating hematologic cancers targeting the sirp - cd47 interaction
HRP20160949T1 (en) Novel compositions and methods for cancer treatment
EP2605799A4 (en) Conjugates, particles, compositions, and related methods
IL218987A0 (en) Methods and compositions for treating cancer
HK1159498A1 (en) Methods and compositions for the treatment of cancer
EP2419136A4 (en) Compositions and methods for treating cancer
EP2340027A4 (en) Methods and compositions for the treatment of cancer
WO2010123759A9 (en) Compositions and methods for treating burns
HRP20130642T1 (en) Methods and compositions for treating cancers
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2437738A4 (en) Methods and compositions for the treatment of cancer
EP2150270A4 (en) Methods and compositions for the treatment of cancer
ZA201007362B (en) Conjugates for the treatment of mesothelioma
WO2011057220A9 (en) Compositions and methods for treating lymphoma
EP2411031A4 (en) Methods and compositions for the treatment of cancer
AU2015201757A1 (en) Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction
EP2252298A4 (en) Compositions and methods for treating lung cancer
LT3067054T (en) Novel compositions and methods for cancer treatment
SI3067054T1 (en) Novel compositions and methods for cancer treatment
AU2007901628A0 (en) Methods and compositions for treating prostate cancer
AU2008903693A0 (en) Compositions and methods for the prevention and treatment of cancer
AU2008905198A0 (en) Compositions and Methods for the Prevention and Treatment of Cancer